RETATRUTIDE 15MG

Retatrutide is an investigational triple-hormone receptor agonist designed to target multiple metabolic pathways involved in appetite regulation, energy balance, and glucose metabolism. It acts on GLP-1, GIP, and glucagon receptors, making it one of the most advanced peptide-based compounds currently being studied for metabolic health and body composition support.

Key Features

• Triple receptor activity (GLP-1, GIP, and glucagon)
• Supports appetite regulation and satiety
• May assist with metabolic function and energy expenditure
• Being investigated for body composition and weight management applications
• Long-acting peptide with ongoing clinical research